These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8096803)

  • 1. High circulating leukaemia inhibitory factor (LIF) in patients with giant cell arteritis: independent regulation of LIF and IL-6 under corticosteroid therapy.
    Lecron JC; Roblot P; Chevalier S; Morel F; Alderman E; Gombert J; Gascan H
    Clin Exp Immunol; 1993 Apr; 92(1):23-6. PubMed ID: 8096803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of IL-11 and leukaemia inhibitory factor (LIF) do not significantly participate in the production of acute-phase proteins by the liver.
    Gabay C; Singwe M; Genin B; Meyer O; Mentha G; LeCoultre C; Vischer T; Guerne PA
    Clin Exp Immunol; 1996 Aug; 105(2):260-5. PubMed ID: 8706331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma.
    Wierzbowska A; Urbańska-Ryś H; Robak T
    Br J Haematol; 1999 May; 105(2):412-9. PubMed ID: 10233412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of leukemia inhibitory factor in biological fluids by radioimmunoassay.
    Ren SG; Seliktar J; Li X; Braunstein GD; Melmed S
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1275-83. PubMed ID: 9543156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased plasma levels of human interleukin for DA1.a cells/leukemia inhibitory factor in sepsis correlate with shock and poor prognosis.
    Villers D; Dao T; Nguyen JM; Bironneau E; Godard A; Moreau M; De Groote D; Nicolas F; Soulillou JP; Anegon I
    J Infect Dis; 1995 Jan; 171(1):232-6. PubMed ID: 7798671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma leukaemia inhibitory factor, interleukin 6 and soluble interleukin 6 receptor levels during cardiopulmonary bypass with extracorporeal circulation.
    Denizot Y; Lorgeot V; Cornu E; Nathan N
    Cytokine; 1998 Apr; 10(4):303-6. PubMed ID: 9617576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of enzymo-immunoassays (EIA) for macrophage colony-stimulating factor (M-CSF) and leukaemia inhibitory factor (LIF) by using the same capture and signal generating polyclonal antibody.
    Fixe P; Lorgeot V; Le Meur Y; Coupey L; Heymann D; Godard A; Praloran V
    Cytokine; 1996 Jul; 8(7):586-91. PubMed ID: 8891440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lipid mediators on the synthesis of leukaemia inhibitory factor and interleukin 6 by human bone marrow stromal cells.
    Denizot Y; Trimoreau F; Praloran V
    Cytokine; 1998 Oct; 10(10):781-5. PubMed ID: 9811531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis.
    Robak T; Gladalska A; Stepień H; Robak E
    Mediators Inflamm; 1998; 7(5):347-53. PubMed ID: 9883970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro regulation of thyroid leukemia inhibitory factor (LIF): marker of hypothyroidism.
    Ren SG; Seliktar J; Li X; Hershman JM; Braunstein GD; Melmed S
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2883-7. PubMed ID: 10443695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ELISA detection of circulating levels of LIF, OSM, and CNTF in septic shock.
    Guillet C; Fourcin M; Chevalier S; Pouplard A; Gascan H
    Ann N Y Acad Sci; 1995 Jul; 762():407-9. PubMed ID: 7668543
    [No Abstract]   [Full Text] [Related]  

  • 12. Release of leukemia inhibitory factor in primate sepsis. Analysis of the role of TNF-alpha.
    Jansen PM; de Jong IW; Hart M; Kim KJ; Aarden LA; Hinshaw LB; Taylor FB; Hack CE
    J Immunol; 1996 Jun; 156(11):4401-7. PubMed ID: 8666813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year enzyme-linked immunosorbent assay follow-up of human interleukin for Da cells/leukemia inhibitory factor in blood and urine of 22 kidney transplant recipients.
    Morel D; Taupin JL; Combe C; Potaux L; Gualde N; Moreau JF
    Transplantation; 1994 Dec; 58(11):1190-5. PubMed ID: 7992361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential production of leukaemia inhibitory factor by blood cell culture in patients with ARDS.
    Gruson D; Hilbert G; Juzan M; Taupin JL; Coulon V; Moreau JF; Gualde N; Gbikpi-Benissan G
    Intensive Care Med; 1998 Apr; 24(4):366-8. PubMed ID: 9609417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukaemia inhibitory factor (LIF) production in pleural effusions: comparison with production of IL-4, IL-8, IL-10 and macrophage-colony stimulating factor (M-CSF).
    Heymann D; L'Her E; NGuyen JM; Raher S; Canfrère I; Coupey L; Fixe P; Chailleux E; De Groote D; Praloran V; Godard A
    Cytokine; 1996 May; 8(5):410-6. PubMed ID: 8726670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemia inhibitory factor concentrations in the bone marrow plasma of healthy subjects and patients with hematologic malignancies.
    Lorgeot V; Trimoreau F; Gachard N; Praloran V; Denizot Y
    Eur Cytokine Netw; 1997 Mar; 8(1):57-9. PubMed ID: 9110149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemia inhibitory factor in long-term adherent layer cultures: increased levels of bioactive protein in leukemia and modulation by IL-4, IL-1 beta, and TNF-alpha.
    Wetzler M; Estrov Z; Talpaz M; Kim KJ; Alphonso M; Srinivasan R; Kurzrock R
    Cancer Res; 1994 Apr; 54(7):1837-42. PubMed ID: 8137298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of interleukin-6, interleukin-10 and leukemia inhibitory factor (LIF) production by peripheral blood cells from patients with systemic lupus erythematosus identifies LIF as a potential marker of disease activity.
    Viallard JF; Taupin JL; Miossec V; Pellegrin JL; Moreau BL
    Eur Cytokine Netw; 1999 Mar; 10(1):17-24. PubMed ID: 10210768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukaemia inhibitory factor is expressed by normal human keratinocytes in vitro and in vivo.
    Paglia D; Kondo S; Ng KM; Sauder DN; McKenzie RC
    Br J Dermatol; 1996 May; 134(5):817-23. PubMed ID: 8736319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.